(87 days)
The Tapered Screw-Vent®T Implants are designed for use in the maxilla or mandible for immediate loading or for loading after a conventional healing period. Implants may be used to replace one or more missing teeth. Immediate loading is indicated when there is good primary stability and an appropriate occlusal load.
The Tapered Screw-Vent® P Implants are designed for use in the maxilla or mandible for loading after a conventional healing period. Implants may be used to replace one or more missing teeth.
The Tapered Screw-Vent® T Implant is an endosseous dental implant. The implant is composed of titanium alloy. The implant section is designed for ease if implantation and with greater surface area for osseointegration. The implant section surface is treated to facilitate osseointegration. In addition, the implant section is tapered with triple-lead threads.
The Tapered Screw-Vent® P Implant is an endosseous dental implant. The implant is composed of titanium alloy and Cancellous-Structured Titanium (CSTi) coating. The implant section is designed for ease of implantation and with greater surface area for osseointegration. The CSTi coating is designed to allow for bone ingrowth. The implant section surface is treated to facilitate osseointegration. In addition, the implant section is tapered with triple-lead threads.
This medical device submission (K101880) is for dental implants and does not include any information about an AI-powered device or software. Therefore, the specific criteria requested for an AI device (like acceptance criteria, sample sizes for test/training sets, expert qualifications, adjudication methods, MRMC studies, or standalone performance) are not applicable to the provided document.
The document focuses on demonstrating substantial equivalence of the Tapered Screw-Vent® T Implant and Tapered Screw-Vent® P Implant to existing predicate devices based on material, design, manufacturing, and non-clinical testing.
Here's the relevant information that is present in the document:
1. Acceptance Criteria and Device Performance:
The document broadly states that "Functional laboratory testing performed in foreseeable operating conditions showed correct operation of the device per its intended use." However, it does not provide specific quantitative acceptance criteria or detailed device performance metrics in a table format as you would expect for an AI device. The general acceptance criteria are conformance to performance specifications and requirements outlined in the "Guidance for Industry and FDA Staff - Class II Special Controls Guidance Document: Root-form Endosseous Dental Implants and Endosseous Dental Implant Abutments."
2. Sample size used for the test set and the data provenance:
Not applicable. No "test set" in the context of an AI device was used. The testing performed was "non-clinical bench testing" to assess functional operation.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
Not applicable. No expert-established ground truth for a "test set" was involved.
4. Adjudication method for the test set:
Not applicable.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
Not applicable. No clinical studies, let alone MRMC studies, were conducted.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
Not applicable.
7. The type of ground truth used:
Not applicable in the context of an AI device. For this device, the "ground truth" for demonstrating safety and effectiveness relied on:
- Predicate Device Equivalence: The primary "ground truth" is that the new devices are substantially equivalent to legally marketed predicate devices with established safety and effectiveness.
- Bench Testing: Functional laboratory testing results served as evidence of device performance under foreseeable operating conditions.
- Regulatory Guidance: Conformance to the "Class II Special Controls Guidance Document: Root-form Endosseous Dental Implants and Endosseous Dental Implant Abutments" provided the framework for acceptable performance and safety.
8. The sample size for the training set:
Not applicable. No "training set" for an AI algorithm was used.
9. How the ground truth for the training set was established:
Not applicable.
In summary, this document is a 510(k) Pre-Market Notification for traditional dental implants, not an AI software/device. Therefore, the questions related to AI-specific evaluation criteria cannot be answered from the provided text.
§ 872.3640 Endosseous dental implant.
(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.